Share on StockTwits

Illumina (NASDAQ:ILMN) SVP Nicholas Naclerio unloaded 2,000 shares of the stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $167.23, for a total transaction of $334,460.00. Following the completion of the transaction, the senior vice president now directly owns 23,146 shares of the company’s stock, valued at approximately $3,870,706. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of Illumina (NASDAQ:ILMN) traded up 1.95% during mid-day trading on Wednesday, hitting $173.8136. The stock had a trading volume of 726,236 shares. Illumina has a 1-year low of $72.77 and a 1-year high of $185.00. The stock’s 50-day moving average is $170.1 and its 200-day moving average is $160.3. The company has a market cap of $24.229 billion and a P/E ratio of 113.89.

Illumina (NASDAQ:ILMN) last released its earnings data on Wednesday, July 23rd. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.07. The company had revenue of $448.00 million for the quarter, compared to the consensus estimate of $426.50 million. During the same quarter in the previous year, the company posted $0.43 earnings per share. The company’s revenue for the quarter was up 29.5% on a year-over-year basis. On average, analysts predict that Illumina will post $2.29 earnings per share for the current fiscal year.

ILMN has been the subject of a number of recent research reports. Analysts at Wedbush upgraded shares of Illumina from a “neutral” rating to an “outperform” rating in a research note on Wednesday. They now have a $200.00 price target on the stock, up previously from $165.00. Separately, analysts at Stifel Nicolaus initiated coverage on shares of Illumina in a research note on Monday, August 11th. They set a “buy” rating and a $200.00 price target on the stock. Finally, analysts at Goldman Sachs raised their price target on shares of Illumina from $184.00 to $187.00 in a research note on Tuesday, August 5th. Four analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $178.92.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Receive News & Ratings for Illumina Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.